Genesis Healthcare, Inc. Share Price Deutsche Boerse AG
Equities
SH11
US37185X1063
Healthcare Facilities & Services
Sales 2021 * | 346.18Cr 323.31Cr 29TCr | Sales 2022 * | - | Capitalization | 1L 1L 1.22Cr |
---|---|---|---|---|---|
Net income 2021 * | -2.2Cr -2.05Cr -183.52Cr | Net income 2022 * | - | EV / Sales 2021 * | 0.95 x |
Net Debt 2021 * | 327.7Cr 306.06Cr 27TCr | Net cash position 2022 * | - 0 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-0.01
x | P/E ratio 2022 * |
-
| Employees | 44,000 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 46.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 01/21/01 | |
Public Communications Contact | - | - | |
Susan Overton
LAW | General Counsel | - | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 02/15/02 | |
John Randazzo
BRD | Director/Board Member | 69 | 02/21/02 |
Chairman | 79 | 02/21/02 |
1st Jan change | Capi. | |
---|---|---|
+26.11% | 8.92TCr | |
-26.29% | 7.61TCr | |
+1.62% | 2.71TCr | |
-10.44% | 1.71TCr | |
-0.14% | 1.68TCr | |
+0.79% | 1.54TCr | |
+76.56% | 1.37TCr | |
+79.78% | 1.33TCr | |
-25.79% | 1.28TCr |